Kredel, Lea I.
Schneidereit, Oliver
Hoffmann, Jörg C.
Siegmund, Britta
Preiß, Jan C. http://orcid.org/0000-0002-0901-1422
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01 GI 0486)
Article History
Accepted: 30 November 2018
First Online: 7 December 2018
Compliance with ethical standards
:
: JCH served as consultant for Astra, Falk, Hexal, Janssen, Pfizer, Steigerwald, and Takeda, and received lecture fees from Falk, Janssen, MSD, Pfizer, and Takeda. BS received a research grant from Pfizer, served as consultant for Falk, Janssen, MSD, Abbvie, Celgene, Lilly, Takeda, Pfizer, and Hospira and received lecture fees from Abbvie, Falk, Ferring, Janssen, MSD, Merck, and Takeda; all money went to the Charité-Universitätsmedizin Berlin, Germany. JCP served as a consultant for MSD, Pfizer, Takeda, and Biogen and received lecture fees from Vifor, Falk, Janssen, Abbvie, Pfizer, Vifor, MSD, and Takeda.
: The local ethics board approved the protocol. All patient-related data were anonymized after open questions had been resolved in responders who provided their contact information.
: Informed consent was assumed if patients sent in their questionnaire. The local data protection commissioner approved the protocol.